Ipriflavone for the treatment of osteoporosis
- 1 May 1997
- journal article
- clinical trial
- Published by Springer Nature in Osteoporosis International
- Vol. 7 (S3) , 174-178
- https://doi.org/10.1007/bf03194367
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Effects of ipriflavone and its metabolites on human articular chondrocytes cultivated in clustersOsteoarthritis and Cartilage, 1996
- Metabolic and bone effects after administration of ipriflavone and salmon calcitonin in postmenopausal osteoporosisBiomedicine & Pharmacotherapy, 1995
- Ipriflavone improves bone density and biomechanical properties of adult male rat bonesCalcified Tissue International, 1995
- Overexpression of estrogen receptor in HTB 96 human osteosarcoma cells results in estrogen-induced growth inhibition and receptor cross talkJournal of Bone and Mineral Research, 1994
- OsteoporosisRheumatology, 1993
- Bone density at various sites for prediction of hip fracturesThe Lancet, 1993
- Effects of ipriflavone on bone mass and calcium metabolism in postmenopausal osteoporosisBone and Mineral, 1992
- A mouse tumor-derived osteolytic factor stimulates bone resorption by a mechanism involving local protaglandins production in boneBiochimica et Biophysica Acta (BBA) - General Subjects, 1985
- Characterization of Cells Isolated and Cultured from Human BoneExperimental Biology and Medicine, 1984
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTJournal of Biological Chemistry, 1951